Table 1

Prevalence of HPV in Edinburgh and Lothian’s routine cervical screening population

Prevalence of HPV
No. tested (% population)HPV +ve (%)HPV –ve (%)HR-HPV +ve (%)HR-HPV +ve only (%)LR-HPV +ve (%)LR-HPV +ve only (%)Unknown HPV type (%)
HPV +ve, all who tested HPV DNA positive (includes any individual who tested positive for HR-HPV and or LR-HPV type(s), in addition to those who were positive by PCR but untypable by the LA assay). HPV –ve, all who did not test HPV DNA positive. HR-HPV +ve, all who tested positive for at least 1 HR-HPV type (mixed infections with low risk types are included). HR-HPV +ve only, all who tested positive for a HR-HPV type or types only. LR-HPV +ve, all who tested positive for at least 1 LR-HPV type (mixed infections with high risk types are included). LR-HPV +ve only, all who tested positive for a LR-HPV type or types only. Unknown HPV type, all who tested positive for HPV using real time PCR but hybridised to none of the 27 probes in the LA assay.
HPV, human papillomavirus; HR, high risk; LA, linear array; LR, low risk; PCR, polymerase chain reaction; U/S, unsatisfactory.
Dyskaryosis
    Negative3089 (89.7)392 (12.7)2697 (87.3)257 (8.3)200 (6.5)93 (3.0)36 (1.2)99 (3.2)
    Borderline114 (3.3)97 (85.1)17 (14.9)82 (71.9)53 (46.5)38 (33.3)9 (7.9)6 (5.3)
    Mild129 (3.7)124 (96.1)5 (3.9)112 (86.8)72 (55.8)46 (35.7)6 (4.6)6 (4.6)
    High grade94 (2.7)88 (93.6)6 (6.4)86 (91.5)76 (80.8)10 (10.6)02 (2.1)
    U/S18 (0.5)4 (22.2)14 (77.8)3 (16.6)3 (16.6)001 (5.5)
Age
    <25734 (21.3)308 (42.0)426 (58.0)260 (35.4)171 (23.3)111 (15.1)22 (2.9)26 (3.5)
    25–35935 (27.2)211 (22.6)724 (77.4)158 (17.0)127 (13.6)44 (4.7)13 (1.34)40 (4.3)
    35–45893 (25.9)116 (13.0)777 (87.0)80 (9.1)69 (7.7)20 (2.2)9 (1.0)27 (3.0)
    45–55603 (17.5)55 (9.1)548 (90.9)33 (5.5)29 (4.8)8 (1.3)4 (0.7)18 (3.0)
    >55279 (8.1)15 (5.4)264 (94.6)9 (3.2)8 (2.9)4 (1.4)3 (1.1)3 (1.1)
Total3444705273954040418751114